Clinical Trial Update: Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated autologous mesenchymal stem cells for mid to late stage knee osteoarthritis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Human Autologous Mesenchymal Stem Cells

Snippet

Sponsor: Jas Chahal | Conditions: Osteoarthritis of Knee | Phase 1, Phase 2 | Status: COMPLETED